Publication | Open Access

A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study

Surgical OncologyPhase Ii TrialMedicineUnresectable High-grade OsteosarcomaMetronomic TherapySurgeryStandard Multimodal TherapyCancer TreatmentOncologyRadiation Oncology